Ryvu Therapeutics S.A. (WSE: RVU)
Poland
· Delayed Price · Currency is PLN
52.20
-1.30 (-2.43%)
Sep 27, 2024, 5:00 PM CET
Ryvu Therapeutics Market Cap
Ryvu Therapeutics has a market cap or net worth of 1.21 billion as of September 30, 2024. Its market cap has decreased by -14.98% in one year.
Market Cap
1.21B
Enterprise Value
1.01B
Revenue
82.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
52.20
Market Cap Chart
Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 1.21B, an increase of 2,035.93%. That is a compound annual growth rate of 26.07%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Krka, d. d. | 18.06B |
NEUCA S.A. | 3.61B |
Sopharma AD | 2.17B |
Synektik Spólka Akcyjna | 1.59B |
Celon Pharma S.A. | 1.49B |
Voxel S.A. | 1.13B |
Selvita S.A. | 1.04B |
Mercator Medical S.A. | 557.89M |